Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markers

Gregory John Sengstock, C. W. Olanow, R. A. Menzies, A. J. Dunn, G. W. Arendash

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Iron has recently been suggested to contribute to the pathogenesis of Parkinson's disease (PD) because of the finding of increased iron levels in the substantia nigra pars compacta (SNc) above those of control patients. Iron is capable of catalyzing numerous reactions which could lead to free radical formation and oxidative damage to DNA, proteins, lipid membranes, and other biological molecules. Neurodegeneration in the SNc of the PD brain may be a consequence of increased iron, which promotes these cytotoxic reactions. To test whether excess iron could play a causative role in the degeneration of nigral neurons, we infused 1.25–6.3 mnol of iron into the rat substantia nigra (SN) unilaterally utilizing two different infusion protocols. All infusates were isosmotic and pH‐balanced in a citrate‐bicarbonate vehicle. Animals were decapitated at either 1 or 2 months postinfusion. Striatal tissue was assayed for biogenic amines by HPLC and the remaining brainstem was processed for histological analysis. Ironstained coronal sections revealed (1) no left/right staining difference with vehicle infusion, (2) a dose‐dependent iron accumulation in the infused SN that was restricted to the zona compacta and dorsal‐most zona reticularis when the lowest iron concentration was infused, and (3) a dose‐dependent reduction in SN volume. Thionine‐stained sections revealed neuronal loss and accompanying reactive gliosis within an area that corresponded closely to that of increased iron staining. These degenerative changes were more extensive in animals infused via a side‐by side vs. a sequential protocol. Neurochemically, there was a highly significant correlation between the amount of iron infused intranigrally and magnitude of reductions in striatal DA, DOPAC, and HVA within the ipsilateral striatum. These data indicate that iron infusion into the SN can cause degenerative changes within the SN and that these changes can be restricted to the SNc region when low amounts of iron are infused. The data further support the hypothesis that iron‐induced degeneration may contribute to the pathogenesis of PD. © 1993 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)67-82
Number of pages16
JournalJournal of Neuroscience Research
Volume35
Issue number1
DOIs
StatePublished - Jan 1 1993

Fingerprint

Corpus Striatum
Substantia Nigra
Iron
Pathology
Parkinson Disease
Zona Reticularis
Staining and Labeling
3,4-Dihydroxyphenylacetic Acid
Nerve Degeneration
Biogenic Amines
Gliosis
Herpes Zoster
Membrane Lipids
DNA Damage
Brain Stem
Free Radicals
Membrane Proteins

Keywords

  • PERL's stain
  • Parkinson's disease
  • dopamine
  • pars compacta

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Infusion of iron into the rat substantia nigra : Nigral pathology and dose‐dependent loss of striatal dopaminergic markers. / Sengstock, Gregory John; Olanow, C. W.; Menzies, R. A.; Dunn, A. J.; Arendash, G. W.

In: Journal of Neuroscience Research, Vol. 35, No. 1, 01.01.1993, p. 67-82.

Research output: Contribution to journalArticle

Sengstock, Gregory John ; Olanow, C. W. ; Menzies, R. A. ; Dunn, A. J. ; Arendash, G. W. / Infusion of iron into the rat substantia nigra : Nigral pathology and dose‐dependent loss of striatal dopaminergic markers. In: Journal of Neuroscience Research. 1993 ; Vol. 35, No. 1. pp. 67-82.
@article{ed6ac0f894d44c4ea51b995a01dd5b21,
title = "Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markers",
abstract = "Iron has recently been suggested to contribute to the pathogenesis of Parkinson's disease (PD) because of the finding of increased iron levels in the substantia nigra pars compacta (SNc) above those of control patients. Iron is capable of catalyzing numerous reactions which could lead to free radical formation and oxidative damage to DNA, proteins, lipid membranes, and other biological molecules. Neurodegeneration in the SNc of the PD brain may be a consequence of increased iron, which promotes these cytotoxic reactions. To test whether excess iron could play a causative role in the degeneration of nigral neurons, we infused 1.25–6.3 mnol of iron into the rat substantia nigra (SN) unilaterally utilizing two different infusion protocols. All infusates were isosmotic and pH‐balanced in a citrate‐bicarbonate vehicle. Animals were decapitated at either 1 or 2 months postinfusion. Striatal tissue was assayed for biogenic amines by HPLC and the remaining brainstem was processed for histological analysis. Ironstained coronal sections revealed (1) no left/right staining difference with vehicle infusion, (2) a dose‐dependent iron accumulation in the infused SN that was restricted to the zona compacta and dorsal‐most zona reticularis when the lowest iron concentration was infused, and (3) a dose‐dependent reduction in SN volume. Thionine‐stained sections revealed neuronal loss and accompanying reactive gliosis within an area that corresponded closely to that of increased iron staining. These degenerative changes were more extensive in animals infused via a side‐by side vs. a sequential protocol. Neurochemically, there was a highly significant correlation between the amount of iron infused intranigrally and magnitude of reductions in striatal DA, DOPAC, and HVA within the ipsilateral striatum. These data indicate that iron infusion into the SN can cause degenerative changes within the SN and that these changes can be restricted to the SNc region when low amounts of iron are infused. The data further support the hypothesis that iron‐induced degeneration may contribute to the pathogenesis of PD. {\circledC} 1993 Wiley‐Liss, Inc.",
keywords = "PERL's stain, Parkinson's disease, dopamine, pars compacta",
author = "Sengstock, {Gregory John} and Olanow, {C. W.} and Menzies, {R. A.} and Dunn, {A. J.} and Arendash, {G. W.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1002/jnr.490350109",
language = "English (US)",
volume = "35",
pages = "67--82",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Infusion of iron into the rat substantia nigra

T2 - Nigral pathology and dose‐dependent loss of striatal dopaminergic markers

AU - Sengstock, Gregory John

AU - Olanow, C. W.

AU - Menzies, R. A.

AU - Dunn, A. J.

AU - Arendash, G. W.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Iron has recently been suggested to contribute to the pathogenesis of Parkinson's disease (PD) because of the finding of increased iron levels in the substantia nigra pars compacta (SNc) above those of control patients. Iron is capable of catalyzing numerous reactions which could lead to free radical formation and oxidative damage to DNA, proteins, lipid membranes, and other biological molecules. Neurodegeneration in the SNc of the PD brain may be a consequence of increased iron, which promotes these cytotoxic reactions. To test whether excess iron could play a causative role in the degeneration of nigral neurons, we infused 1.25–6.3 mnol of iron into the rat substantia nigra (SN) unilaterally utilizing two different infusion protocols. All infusates were isosmotic and pH‐balanced in a citrate‐bicarbonate vehicle. Animals were decapitated at either 1 or 2 months postinfusion. Striatal tissue was assayed for biogenic amines by HPLC and the remaining brainstem was processed for histological analysis. Ironstained coronal sections revealed (1) no left/right staining difference with vehicle infusion, (2) a dose‐dependent iron accumulation in the infused SN that was restricted to the zona compacta and dorsal‐most zona reticularis when the lowest iron concentration was infused, and (3) a dose‐dependent reduction in SN volume. Thionine‐stained sections revealed neuronal loss and accompanying reactive gliosis within an area that corresponded closely to that of increased iron staining. These degenerative changes were more extensive in animals infused via a side‐by side vs. a sequential protocol. Neurochemically, there was a highly significant correlation between the amount of iron infused intranigrally and magnitude of reductions in striatal DA, DOPAC, and HVA within the ipsilateral striatum. These data indicate that iron infusion into the SN can cause degenerative changes within the SN and that these changes can be restricted to the SNc region when low amounts of iron are infused. The data further support the hypothesis that iron‐induced degeneration may contribute to the pathogenesis of PD. © 1993 Wiley‐Liss, Inc.

AB - Iron has recently been suggested to contribute to the pathogenesis of Parkinson's disease (PD) because of the finding of increased iron levels in the substantia nigra pars compacta (SNc) above those of control patients. Iron is capable of catalyzing numerous reactions which could lead to free radical formation and oxidative damage to DNA, proteins, lipid membranes, and other biological molecules. Neurodegeneration in the SNc of the PD brain may be a consequence of increased iron, which promotes these cytotoxic reactions. To test whether excess iron could play a causative role in the degeneration of nigral neurons, we infused 1.25–6.3 mnol of iron into the rat substantia nigra (SN) unilaterally utilizing two different infusion protocols. All infusates were isosmotic and pH‐balanced in a citrate‐bicarbonate vehicle. Animals were decapitated at either 1 or 2 months postinfusion. Striatal tissue was assayed for biogenic amines by HPLC and the remaining brainstem was processed for histological analysis. Ironstained coronal sections revealed (1) no left/right staining difference with vehicle infusion, (2) a dose‐dependent iron accumulation in the infused SN that was restricted to the zona compacta and dorsal‐most zona reticularis when the lowest iron concentration was infused, and (3) a dose‐dependent reduction in SN volume. Thionine‐stained sections revealed neuronal loss and accompanying reactive gliosis within an area that corresponded closely to that of increased iron staining. These degenerative changes were more extensive in animals infused via a side‐by side vs. a sequential protocol. Neurochemically, there was a highly significant correlation between the amount of iron infused intranigrally and magnitude of reductions in striatal DA, DOPAC, and HVA within the ipsilateral striatum. These data indicate that iron infusion into the SN can cause degenerative changes within the SN and that these changes can be restricted to the SNc region when low amounts of iron are infused. The data further support the hypothesis that iron‐induced degeneration may contribute to the pathogenesis of PD. © 1993 Wiley‐Liss, Inc.

KW - PERL's stain

KW - Parkinson's disease

KW - dopamine

KW - pars compacta

UR - http://www.scopus.com/inward/record.url?scp=0027221546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027221546&partnerID=8YFLogxK

U2 - 10.1002/jnr.490350109

DO - 10.1002/jnr.490350109

M3 - Article

C2 - 7685399

AN - SCOPUS:0027221546

VL - 35

SP - 67

EP - 82

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 1

ER -